Results 101 to 110 of about 29,117 (272)

Severe Hypertension and Hematologic Abnormalities in Pseudoxanthoma Elasticum: A Pediatric Case Report

open access: yesThe Journal of Clinical Hypertension, Volume 28, Issue 4, April 2026.
ABSTRACT Pseudoxanthoma elasticum (PXE) is a rare autosomal recessive disorder caused by pathogenic variants in ABCC6, leading to progressive calcification of elastic fibers. Although PXE typically presents in adolescence with dermatologic or ocular manifestations, early vascular involvement, including pediatric hypertension, is increasingly recognized.
Hana Flogelova   +8 more
wiley   +1 more source

Scrotal Calcinosis [PDF]

open access: yesJournal of General Internal Medicine, 2016
Michael, Insel, Sara, Swenson
openaire   +5 more sources

In systemic sclerosis skin perfusion of hands is reduced and may predict the occurrence of new digital ulcers [PDF]

open access: yes, 2017
Systemic sclerosis (SSc) patients are at high risk for the development of ischemic digital ulcers (DUs). The aim of this study was to assess in SSc patients a correlation between skin perfusion evaluated by LDPI and DUs and to evaluate the prognostic ...
Barbano, Biagio   +6 more
core   +1 more source

Transition From Juvenile Dermatomyositis to Spondyloarthritis: A Novel Overlapping Inflammatory Phenotype

open access: yesACR Open Rheumatology, Volume 8, Issue 3, March 2026.
Objective Juvenile dermatomyositis (JDM) is a rare childhood inflammatory myopathy, whereas spondyloarthritis (SpA) is an inflammatory arthropathy characterized by enthesitis and peripheral or axial involvement. We describe a series of patients diagnosed with JDM in childhood who later fulfilled classification criteria for SpA, a sequential phenotype ...
Austen Grooms   +3 more
wiley   +1 more source

Comparison of the Utility and Validity of Three Scoring Tools to Measure Skin Involvement in Patients With Juvenile Dermatomyositis [PDF]

open access: yes, 2016
OBJECTIVE: To compare the abbreviated Cutaneous Assessment Tool (CAT), Disease Activity Score (DAS), and Myositis Intention to Treat Activity Index (MITAX) and correlate them with the physician's 10-cm skin visual analog scale (VAS) in order to define ...
Almeida, B   +9 more
core   +1 more source

Pioneers in Dermatology and Venereology: An interview with Professor Eli Sprecher

open access: yes
Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 5, Page 732-735, May 2026.
Eli Sprecher
wiley   +1 more source

Concurrent Psoriasis and Dermatomyositis: Retrospective Analysis and Literature Review

open access: yesJEADV Clinical Practice, Volume 5, Issue 1, Page 205-210, March 2026.
ABSTRACT Background Psoriasis (PsO) and dermatomyositis (DM) are both autoimmune‐mediated, inflammatory conditions. The concurrence of PsO and DM is rare, and literature on their relationship remains limited. Additionally, cutaneous DM can be challenging to clinically diagnosis, often presenting with psoriasiform clinical features.
Emily R. Gordon   +5 more
wiley   +1 more source

Calcinosis cutis universalis - a rare manifestation of systemic lupus erthymatosus

open access: yesSouth African Journal of Radiology, 2012
Calcinosis cutis (or skin and subcutaneous calcification) is a feature of a variety of rheumatic conditions, most commonly dermatomyositis and scleroderma, but is rarely reported in systemic lupus erythematosus (SLE ). When calcinosis cutis does occur in
farhana ebrahim suleman   +1 more
doaj   +1 more source

A proposed role for sepsis in the pathogenesis of myocardial calcification [PDF]

open access: yes, 2017
Myocardial calcification is a rare and life-threatening condition that is a recognised complication of ischaemic heart disease, cardiac surgery, rheumatic fever and myocarditis.
AROMATARIO, MARIAROSARIA   +7 more
core   +1 more source

Imaging calcinosis in patients with systemic sclerosis by radiography, computerised tomography and magnetic resonance imaging.

open access: yesSeminars in Arthritis & Rheumatism, 2019
INTRODUCTION Objective outcome measures are needed to facilitate clinical trials of much needed treatments for calcinosis in systemic sclerosis (SSc).
M. Hughes   +8 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy